Citation APA
Jerusalem, G., Farah, S., Courtois, A., Chirgwin, J., Aebi, S., Karlsson, P., Neven, P., Hitre, E., Graas, M.-P., Simoncini, E., Abdi, E., Kamby, C., Thompson, A., Loibl, S., Gavila, J., Kuroi, K., Marth, C., Müller, B. M. B., O'Reilly, S., Gombos, A., Ruhstaller, T., Burstein, H. H., Rabaglio, M., Ruepp, B., Ribi, K., Viale, G., Gelber, R., Coates, A. A., Loi, S., Goldhirsch, A., Regan, M., & Colleoni, M. A. (2021). Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy. Annals of oncology, 32(10), 1256-1266. doi:10.1016/j.annonc.2021.07.017
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/332276